Skip to main content
Log in

Inhibitory effect of the anorexic compound oleoylethanolamide on gastric emptying in control and overweight mice

  • Original Article
  • Published:
Journal of Molecular Medicine Aims and scope Submit manuscript

Abstract

Gastric emptying regulates food intake. Oleoylethanolamide (OEA), an endogenous acylethanolamide chemically related to the endocannabinoid anandamide, inhibits food intake, but its effect on gastric emptying is unknown. Here, we investigated the effect and the role of OEA on gastric emptying in mice fed either a standard (STD) or a high-fat diet (HFD) for 14 weeks. Gastric emptying was reduced by OEA, but not by its saturated analog, palmitoylethanolamide. The effect of OEA was unaffected by rimonabant (cannabinoid CB1 receptor antagonist), SR144528 (cannabinoid CB2 receptor antagonist), 5′-iodoresiniferatoxin (transient receptor potential vanilloid type 1 antagonist), or MK886 (peroxisome proliferator-activated receptor-α) antagonist. Compared to STD mice, HFD mice showed delayed gastric emptying and higher levels of gastric OEA. HFD-induced increase in OEA levels was accompanied by increased expression of the OEA-synthesizing enzyme N-acyl-phosphatidylethanolamine-selective phospholipase D and decreased expression of the OEA-degrading enzyme fatty acid amide hydrolase. These results might suggest that elevation of gastric OEA could possibly contribute to the delayed gastric emptying observed in HFD-fed animals. HFD regulates OEA levels in the stomach through an increase of its biosynthesis and a decrease of its enzymatic degradation. The inhibitory effect of OEA on gastric emptying here observed might underlie part of the anorexic effects of this compound previously reported.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Abbreviations

AA-5-HT:

N-arachidonoylserotonin

2-AG:

2-arachidonoylglycerol

DMSO:

Dimethylsulfoxide

FAAH:

Fatty acid amide hydrolase

HFD:

High-fat diet

OEA:

Oleoylethanolamide

I-RTX:

5′-iodoresiniferatoxin

NAPE-PLD:

N-acyl-phosphatidylethanolamine-selective phospholipase D

PEA:

Palmitoylethanolamide

PPAR:

Peroxisome proliferator-activated receptor

RT-PCR:

Reverse-transcription polymerase chain reaction

TRPV1:

Transient receptor potential vanilloid type-1

STD:

Standard diet

References

  1. Lo Verme J, Gaetani S, Fu J, Oveisi F, Burton K, Piomelli D (2005) Regulation of food intake by oleoylethanolamide. Cell Mol Life Sci 62:708–716

    Article  PubMed  CAS  Google Scholar 

  2. Matias I, Gonthier MP, Petrosino S, Docimo L, Capasso R, Hoareau L, Monteleone P, Roche R, Izzo AA, Di Marzo V (2007) Role and regulation of acylethanolamides in energy balance: focus on adipocytes and beta-cells. Br J Pharmacol 152:676–690

    Article  PubMed  CAS  Google Scholar 

  3. O’Sullivan SE (2007) Cannabinoids go nuclear: evidence for activation of peroxisome proliferator-activated receptors. Br J Pharmacol 152:576–582

    Article  PubMed  CAS  Google Scholar 

  4. Proulx K, Cota D, Castaneda TR, Tschop MH, D’Alessio DA, Tso P, Woods SC, Seeley RJ (2005) Mechanisms of oleoylethanolamide-induced changes in feeding behavior and motor activity. Am J Physiol Regul Integr Comp Physiol 289:R729–R737

    PubMed  CAS  Google Scholar 

  5. Rodriguez de Fonseca F, Navarro M, Gomez R, Escuredo L, Nava F, Fu J, Murillo-Rodriguez E, Giuffrida A, LoVerme J, Gaetani S, Kathuria S, Gall C, Piomelli D (2001) An anorexic lipid mediator regulated by feeding. Nature 414:209–212

    Article  PubMed  CAS  Google Scholar 

  6. Fu J, Gaetani S, Oveisi F, Lo Verme J, Serrano A, Rodriguez De Fonseca F, Rosengarth A, Luecke H, Di Giacomo B, Tarzia G, Piomelli D (2003) Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-α. Nature 425:90–93

    Article  PubMed  CAS  Google Scholar 

  7. Gaetani S, Oveisi F, Piomelli D (2003) Modulation of meal pattern in the rat by the anorexic lipid mediator oleoylethanolamide. Neuropsychopharmacology 28:1311–1316

    Article  PubMed  CAS  Google Scholar 

  8. Guzman M, Lo Verme J, Fu J, Oveisi F, Blazquez C, Piomelli D (2004) Oleoylethanolamide stimulates lipolysis by activating the nuclear receptor peroxisome proliferator-activated receptor alpha (PPAR-alpha). J Biol Chem 279:27849–27854

    Article  PubMed  CAS  Google Scholar 

  9. Nielsen MJ, Petersen G, Astrup A, Hansen HS (2004) Food intake is inhibited by oral oleoylethanolamide. J Lipid Res 45:1027–1029

    Article  PubMed  CAS  Google Scholar 

  10. Fu J, Oveisi F, Gaetani S, Lin E, Piomelli D (2005) Oleoylethanolamide, an endogenous PPAR-alpha agonist, lowers body weight and hyperlipidemia in obese rats. Neuropharmacology 48:1147–1153

    Article  PubMed  CAS  Google Scholar 

  11. Movahed P, Jonsson BA, Birnir B, Wingstrand JA, Jorgensen TD, Ermund A, Sterner O, Zygmunt PM, Hogestatt ED (2005) Endogenous unsaturated C18 N-acylethanolamines are vanilloid receptor (TRPV1) agonists. J Biol Chem 280:38496–38504

    Article  PubMed  CAS  Google Scholar 

  12. Wang X, Miyares RL, Ahern GP (2005) Oleoylethanolamide excites vagal sensory neurones, induces visceral pain and reduces short-term food intake in mice via capsaicin receptor TRPV1. J Physiol 564:541–547

    Article  PubMed  CAS  Google Scholar 

  13. Petersen G, Sorensen C, Schmid PC, Artmann A, Tang-Christensen M, Hansen SH, Larsen PJ, Schmid HH, Hansen HS (2006) Intestinal levels of anandamide and oleoylethanolamide in food-deprived rats are regulated through their precursors. Biochim Biophys Acta 1761:143–150

    PubMed  CAS  Google Scholar 

  14. Fu J, Astarita G, Gaetani S, Kim J, Cravatt BF, Mackie K, Piomelli D (2007) Food intake regulates oleoylethanolamide formation and degradation in the proximal small intestine. J Biol Chem 282:1518–1528

    Article  PubMed  CAS  Google Scholar 

  15. Yang Y, Chen M, Georgeson KE, Harmon CM (2007) Mechanism of oleoylethanolamide on fatty acid uptake in small intestine after food intake and body weight education. Am J Physiol Regul Integr Comp Physiol 292:R235–R241

    PubMed  CAS  Google Scholar 

  16. Cuomo R, Sarnelli G (2004) Food intake and gastrointestinal motility. A complex interplay. Nutr Metab Cardiovasc Dis 14:173–179

    Article  PubMed  CAS  Google Scholar 

  17. Park MI, Camilleri M (2005) Gastric motor and sensory functions in obesity. Obes Res 13:491–500

    Article  PubMed  Google Scholar 

  18. Cummings DE, Overduin J (2007) Gastrointestinal regulation of food intake. J Clin Invest 117:13–23

    Article  PubMed  CAS  Google Scholar 

  19. Hellstrom PM, Naslund E (2001) Interactions between gastric emptying and satiety, with special reference to glucagon-like peptide-1. Physiol Behav 74:735–741

    Article  PubMed  CAS  Google Scholar 

  20. Serrano A, Del Arco I, Javier Pavon F, Macias M, Perez-Valero V, Rodriguez de Fonseca F (2008) The cannabinoid CB1 receptor antagonist SR141716A (Rimonabant) enhances the metabolic benefits of long-term treatment with oleoylethanolamide in Zucker rats. Neuropharmacology 54:226–234

    Article  PubMed  CAS  Google Scholar 

  21. Darmani NA, Izzo AA, Degenhardt B, Valenti M, Scaglione G, Capasso R, Sorrentini I, Di Marzo V (2005) Involvement of the cannabimimetic compound, N-palmitoyl-ethanolamine, in inflammatory and neuropathic conditions: review of the available pre-clinical data, and first human studies. Neuropharmacology 48:1154–1163

    Article  PubMed  CAS  Google Scholar 

  22. Capasso R, Matias I, Lutz B, Borrelli F, Capasso F, Marsicano G, Mascolo N, Petrosino S, Monory K, Valenti M, Di Marzo V, Izzo AA (2005) Fatty acid amide hydrolase controls mouse intestinal motility in vivo. Gastroenterology 129:941–951

    Article  PubMed  CAS  Google Scholar 

  23. Collino M, Aragno M, Mastrocola R, Benetti E, Gallicchio M, Dianzani C, Danni O, Thiemermann C, Fantozzi R (2006) Oxidative stress and inflammatory response evoked by transient cerebral ischemia/reperfusion: effects of the PPAR-alpha agonist WY14643. Free Radic Biol Med 41:579–589

    Article  PubMed  CAS  Google Scholar 

  24. Di Marzo V, Capasso R, Matias I, Aviello G, Petrosino S, Borrelli F, Orlando P, Capasso F, Izzo AA (2008) The role of endocannabinoids in the regulation of gastric emptying: alterations in mice fed a high fat diet. Br J Pharmacol Jan 28 [Epub ahead of print]

  25. El-Salhy M (2001) Gastric emptying in an animal model of human diabetes type 1: relation to endocrine cells. Acta Diabetol 38:139–144

    Article  PubMed  CAS  Google Scholar 

  26. Bisogno T, Berrendero F, Ambrosino G, Cebeira M, Ramos JA, Fernandez-Ruiz JJ, Di Marzo V (1999) Brain regional distribution of endocannabinoids: implications for their biosynthesis and biological function. Biochem Biophys Res Commun 256:377–380

    Article  PubMed  CAS  Google Scholar 

  27. Izzo AA, Aviello G, Petrosino S, Orlando P, Marsicano G, Lutz B, Borrelli F, Capasso E, Nigam S, Capasso D, Di Marzo V (2008) Increased endocannabinoid levels reduce the development of precancerous lesions in the mouse colon. J Mol Med 86:89–98

    Article  PubMed  CAS  Google Scholar 

  28. D’Argenio G, Petrosino S, Gianfrani C, Valenti M, Scaglione G, Grandone I, Nigam S, Sorrentini I, Mazzarella G, Di Marzo V (2007) Overactivity of the intestinal endocannabinoid system in celiac disease and in methotrexate-treated rats. J Mol Med 85:523–530

    Article  PubMed  CAS  Google Scholar 

  29. Bisogno T, Melck D, De Petrocellis L, Bobrov MYu, Gretskaya NM, Bezuglov VV, Sitachitta N, Gerwick WH, Di Marzo V (1998) Arachidonoylserotonin and other novel inhibitors of fatty acid amide hydrolase. Biochem Biophys Res Commun 248:515–522

    Article  PubMed  CAS  Google Scholar 

  30. Suardiaz M, Estivill-Torrus G, Goicoechea C, Bilbao A, Rodriguez de Fonseca F (2007) Analgesic properties of oleoylethanolamide (OEA) in visceral and nflammatory pain. Pain 133:99–110

    Article  PubMed  CAS  Google Scholar 

  31. Ambrosini A, Zolese G, Ambrosi S, Ragni L, Tiano L, Littarru G, Bertoli E, Mantero F, Boscaro M, Balercia G (2006) Oleoylethanolamide protects human sperm cells from oxidation stress: studies on cases of idiopathic infertility. Biol Reprod 74: 659–665

    Article  PubMed  CAS  Google Scholar 

  32. Jonsson KO, Vandevoorde S, Lambert DM, Tiger G, Fowler CJ (2001) Effects of homologues and analogues of palmitoylethanolamide upon the inactivation of the endocannabinoid anandamide. Br J Pharmacol 133:1263–1275

    Article  PubMed  CAS  Google Scholar 

  33. Duncan M, Davison JS, Sharkey KA (2005) Review article: endocannabinoids and their receptors in the enteric nervous system. Aliment Pharmacol Ther 22:667–683

    Article  PubMed  CAS  Google Scholar 

  34. Massa F, Storr M, Lutz B (2005) The endocannabinoid system in the physiology and pathophysiology of the gastrointestinal tract. J Mol Med 83:944–954

    Article  PubMed  CAS  Google Scholar 

  35. Di Marzo V, Izzo AA (2006) Endocannabinoid overactivity and intestinal inflammation. Gut 55:1373–1376

    Article  PubMed  CAS  Google Scholar 

  36. Izzo AA (2007) The cannabinoid CB(2) receptor: a good friend in the gut. Neurogastroenterol Motil 19:704–708

    Article  PubMed  CAS  Google Scholar 

  37. Ahern GP (2003) Activation of TRPV1 by the satiety factor oleoylethanolamide. J Biol Chem 278:30429–30434

    Article  PubMed  CAS  Google Scholar 

  38. Holzer P (2004) TRPV1 and the gut: from a tasty receptor for a painful vanilloid to a key player in hyperalgesia. Eur J Pharmacol 500:231–241

    Article  PubMed  CAS  Google Scholar 

  39. Overton HA, Babbs AJ, Doel SM, Fyfe MC, Gardner LS, Griffin G, Jackson HC, Procter MJ, Rasamison CM, Tang-Christensen M, Widdowson PS, Williams GM, Reynet C (2006) Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents. Cell Metab 3:167–175

    Article  PubMed  CAS  Google Scholar 

  40. Wisen O, Hellstrom PM (1995) Gastrointestinal motility in obesity. J Intern Med 237:411–418

    Article  PubMed  CAS  Google Scholar 

  41. Asakawa A, Inui A, Ueno N, Makino S, Uemoto M, Fujino MA, Kasuga M (2003) Ob/ob mice as a model of delayed gastric emptying. J Diabetes Complications 17:27–28

    Article  PubMed  Google Scholar 

  42. Di Marzo V, Goparaju SK, Wang L, Liu J, Batkai S, Jarai Z, Fezza F, Miura GI, Palmiter RD, Sugiura T, Kunos G (2001) Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 410:822–825

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by Prin, Regione Campania, “Fondazione Enrico ed Enrica Sovena,” Epitech, S.r.l. (to SP and VDM), and Sanofi-Aventis (to VDM).

Competing interests

The authors declare no competing interests.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Vincenzo Di Marzo or Angelo A. Izzo.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Aviello, G., Matias, I., Capasso, R. et al. Inhibitory effect of the anorexic compound oleoylethanolamide on gastric emptying in control and overweight mice. J Mol Med 86, 413–422 (2008). https://doi.org/10.1007/s00109-008-0305-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00109-008-0305-7

Keywords

Navigation